scholarly article | Q13442814 |
P819 | ADS bibcode | 1989PNAS...86.2433F |
P356 | DOI | 10.1073/PNAS.86.7.2433 |
P932 | PMC publication ID | 286927 |
P698 | PubMed publication ID | 2648404 |
P5875 | ResearchGate publication ID | 20508625 |
P50 | author | Robert Gallo | Q469904 |
Eva Maria Fenyö | Q89369110 | ||
Jan Albert | Q39183357 | ||
P2093 | author name string | Franchini G | |
Biberfeld G | |||
De Rossi A | |||
Jagodzinski L | |||
Bosch M | |||
Fargnoli KA | |||
Giombini F | |||
P2860 | cites work | The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions | Q42653163 |
The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animals | Q42654446 | ||
Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. | Q42658314 | ||
Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. | Q43967221 | ||
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. | Q44238578 | ||
The AIDS virus | Q44559514 | ||
The sor gene of HIV-1 is required for efficient virus transmission in vitro | Q45831189 | ||
Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses | Q45831194 | ||
Human immunodeficiency virus: the eighth gene | Q45831425 | ||
Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus | Q45832058 | ||
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group | Q45832109 | ||
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 | ||
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients | Q45848343 | ||
Human and simian immunodeficiency retroviruses: activation and differential transactivation of gene expression | Q46412923 | ||
Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDS | Q52849903 | ||
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. | Q53883523 | ||
DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 | ||
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
DNA sequence analysis with a modified bacteriophage T7 DNA polymerase | Q24605322 | ||
A new method for sequencing DNA | Q24605576 | ||
Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 | ||
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma | Q29615115 | ||
Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. | Q33639547 | ||
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. | Q33927613 | ||
Isolation of a new human retrovirus from West African patients with AIDS. | Q34038984 | ||
Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 | ||
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques | Q34049156 | ||
Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency | Q34055177 | ||
Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS | Q34055350 | ||
A second post-transcriptional trans-activator gene required for HTLV-III replication | Q34162178 | ||
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys | Q34162184 | ||
Identification of a protein encoded by the vpu gene of HIV-1. | Q34163678 | ||
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. | Q34186306 | ||
Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA. | Q35583581 | ||
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). | Q35617653 | ||
The effect of helper virus on Abelson virus-induced transformation of lymphoid cells | Q36340152 | ||
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses | Q36470925 | ||
Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis | Q41886681 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 5 | |
P304 | page(s) | 2433-2437 | |
P577 | publication date | 1989-04-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone | |
P478 | volume | 86 |
Q37517645 | A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support |
Q46444674 | A highly divergent HIV-2-related isolate |
Q37844065 | Animal models for development of an AIDS vaccine |
Q36784415 | Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia |
Q34323939 | CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses |
Q45859740 | Comparison of Linear Antigenic Sites in the Envelope Proteins of Human Immunodeficiency Virus (HIV) Type 2 and Type 1 |
Q40024144 | Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection |
Q36698091 | Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates |
Q36797933 | Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4. |
Q36701891 | Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication |
Q36641861 | Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain |
Q24540298 | Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor |
Q33938392 | Evolution of the primate lentiviruses: evidence from vpx and vpr |
Q33604826 | Evolutionary origin of human and simian immunodeficiency viruses |
Q40760950 | Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2. |
Q36637244 | Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology |
Q33814659 | Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1. |
Q36811248 | Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain |
Q39242650 | Human infection by genetically diverse SIVSM-related HIV-2 in west Africa |
Q37546827 | Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity |
Q36803768 | Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins |
Q36699146 | In vivo genetic variability of the human immunodeficiency virus type 2 V3 region |
Q35861329 | Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev |
Q41687797 | Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer |
Q36797905 | Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope |
Q39875204 | Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein |
Q36287468 | Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity |
Q36801331 | Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate |
Q43897670 | Neutralizing Monoclonal Antibody against an External Envelope Glycoprotein (gp110) of SIVmac251 |
Q35839457 | Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120 |
Q36783146 | Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects |
Q36699125 | Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2. |
Q44079254 | Specificity of new peptide immunoassays versus other immunoassays and agglutination tests for detection of HIV antibody in African Sera |
Q36684349 | Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus |
Q33849520 | The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages |
Q33935811 | The nef gene of simian immunodeficiency virus SIVmac1A11 |
Q36685908 | Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. |
Q36632917 | Variability of the env gene in cynomolgus macaques persistently infected with human immunodeficiency virus type 2 strain ben. |
Search more.